Commentary: No-test medication abortion: A sample protocol for increasing access during a pandemic and beyond
Authors:
- Elizabeth G. RaymondERElizabeth G. Raymond
- Daniel GrossmanDGDaniel Grossman
- Alice MarkAMAlice Mark
- Ushma D. UpadhyayUUUshma D. Upadhyay
- Gillian DeanGDGillian Dean
- Mitchell D. CreininMCMitchell D. Creinin
- Leah CoplonLCLeah Coplon
- Jessica M. AtrioJAJessica M. Atrio
- DeShawn TaylorDTDeShawn Taylor
- Marji GoldMGMarji Gold
Top Cited Papers
- 1 June 2020
- journal article
- editorial
- Published by Elsevier in Contraception
- Vol. 101 (6) , 361-366
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Ectopic PregnancyClinical Obstetrics & Gynecology, 2012
- Attitudes and Decision Making Among Women Seeking Abortions at One U.S. ClinicPerspectives on Sexual and Reproductive Health, 2012
- Regional differences in surgical intervention following medical termination of pregnancy provided by telemedicineActa Obstetricia et Gynecologica Scandinavica, 2011
- Alternatives to routine ultrasound for eligibility assessment prior to early termination of pregnancy with mifepristone-misoprostolBJOG: An International Journal of Obstetrics & Gynaecology, 2010
- Alternatives to a Routine Follow-Up Visit for Early Medical AbortionObstetrics & Gynecology, 2010
- Feasibility of telephone follow-up after medical abortionContraception, 2010
- Ectopic PregnancyNew England Journal of Medicine, 2009
- Could American women use mifepristone-misoprostol pills safely with less medical supervision?Contraception, 2002
- Can women use medical abortion without medical supervision?Reproductive Health Matters, 1997
- Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue: Study in 16, 369 womenActa Obstetricia et Gynecologica Scandinavica, 1992